ORASURE TECHNOLOGIES INC
OraSure Technologies, Inc. (OSUR: NASDAQ) operates as a global diagnostics and sample management solutions company headquartered in Bethlehem, Pennsylvania. The company transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are, operating through a… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What ORASURE TECHNOLOGIES INC does
In the company’s own words
OraSure Technologies, Inc. (OSUR: NASDAQ) operates as a global diagnostics and sample management solutions company headquartered in Bethlehem, Pennsylvania. The company transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are, operating through a single business unit covering multiple product lines with integrated commercial and innovation teams.
The company's business comprises two principal segments: diagnostics products and sample management solutions. OraSure's diagnostic portfolio includes rapid point-of-care tests for infectious diseases such as HIV, hepatitis C virus, syphilis, sickle cell disease, and COVID-19, sold in both professional and over-the-counter formats across the United States and internationally. The company's flagship OraQuick® platform represents a significant revenue contributor, generating approximately $49.8 million in 2025. The InteliSwab® COVID-19 Rapid Test, while declining from peak pandemic volumes, continues as a material product line. In November 2025, OraSure acquired BioMedomics, Inc., adding the SickleSCAN® test, the world's first rapid point-of-care test for sickle cell disease diagnosis.
The sample management solutions segment provides collection, stabilization, transportation, and storage systems for DNA, RNA, and biological samples under brands including Oragene®, ORAcollect®, OMNIgene®, and Colli-Pee®. These products serve academic research, commercial diagnostics, pharmaceutical, biotech, and companion animal markets. Genomics products generated approximately $31.5 million in 2025 revenues.
OraSure maintains manufacturing operations in Bethlehem, Pennsylvania, with contract manufacturing relationships in Thailand and Canada. The company employs 500 full-time employees as of December 31, 2025. The company markets products through direct sales forces in key markets and independent distributors internationally, reaching hospitals, clinics, laboratories, community-based organizations, government agencies, and retail consumers.
The company holds significant intellectual property including patents protecting its innovative sampling tools, sample preservatives, and diagnostic technologies. OraSure maintains strategic relationships with government agencies, including contracts with the U.S. Department of Defense and funding from the Biomedical Advanced Research and Development Authority for product development initiatives. The company's website is www.oraquick.com.
Company details
- Sector
- Healthcare
- Industry
- Surgical & Medical Instruments
- Headquarters
- BETHLEHEM, PA
- Fiscal year end
- December
- CIK
- 1116463
- SIC
- 3841
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns ORASURE TECHNOLOGIES INC — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · ORASURE TECHNOLOGIES INC’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do ORASURE TECHNOLOGIES INC and its peers compare on margins and cash generation over ten years?”
- “Where did five years of ORASURE TECHNOLOGIES INC's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in ORASURE TECHNOLOGIES INC's last four quarterly filings that the numbers alone won't show?”